Synthesis of antisense oligonucleotides carrying modified 2-5A molecules at their 5′-termini and their properties

Bioconjugate Chemistry

Volumn 14, Issue 3, 2003, Pages 690-696

  Ueno, Yoshihito ^a   Kato, Yoichiro ^a   Okatani, Shusaku ^a   Ishida, Norihisa ^a   Nakanishi, Masayuki ^a   Kitade, Yukio ^a  

^a GIFU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEIC ACIDS; OLIGONUCLEOTIDES; PHOSPHATASES; PHOSPHATES; SYNTHESIS (CHEMICAL);

ALKALINE PHOSPHATASE; ANTISENSE; ANTISENSE OLIGONUCLEOTIDES; HUMAN RNASE L; HYDROXYALKYLS; PHOSPHORAMIDITES; PROPERTY; SYNTHESISED; TETRAMERS;

OLIGOMERS;

8 METHYLADENOSINE; ADENOSINE DERIVATIVE; ALKALINE PHOSPHATASE; ALKYL GROUP; ANTISENSE OLIGONUCLEOTIDE; COMPLEMENTARY RNA; DNA; PHOSPHORAMIDIC ACID DERIVATIVE; RIBONUCLEASE; RNA; UNCLASSIFIED DRUG;

ARTICLE; CHIMERA; DNA SYNTHESIS; ENZYME ACTIVATION; MOLECULE; TERMINAL SEQUENCE;

EID: 0037908878     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc020072a     Document Type: Article

References (20)

1. Uhlmann, E., and Peyman, A. (1990) Antisense oligonucleotides: a new therapeutic principle. Chem. Rev. 90, 544-584.
2. Milligan, J. F., Matteucci, M. D., and Martin, J. C. (1993) Current concepts in antisense drug design. J. Med. Chem. 36, 1923-1937.
3. Stein, C. A. (1999) Keeping the biotechnology of antisense in context. Nat. Biotechnol. 17, 209.
4. Mesmaeker, A. D., Altmann, K.-H., Waldner, A., and Wendeborn, S. (1995) Backbone modifications in oligonucleotides and peptide nucleic acid systems. Curr. Opin. Struct. Biol. 5, 343-355, and references therein.
5. Player, M., and Torrence, P. F. (1998) The 2-5A system: modulation of viral and cellular processes through acceleration of RNA degradation. Pharmacol. Ther. 78, 55-113.
6. Lesiak, K., Khamnei, S., and Torrence, P. F. (1993) 2′,5′-Oligoadenylate: antisense chimeras - synthesis and properties. Bioconjugate Chem. 4, 467-472.
7. Maran, A., Maitra, R. K., Kumar, A., Dong, B., Xiao, W., Li, G., Williams, B. R. G., Torrence, P. F., and Silverman, R. H. (1994) Blockage of NF-κB signaling by selective ablation of an mRNA target by 2-5A antisense chimeras. Science 265, 789-792.
8. Cirino, N. M., Li, G., Xiao, W., Torrence, P. F., and Silverman, R. H. (1997) Targeting RNA decay with 2′,5′ oligoadenylate-antisense in respiratory syncytial virus-infected cells. Proc. Natl. Acad. Sci. U.S.A. 94, 1937-1942.
9. Player, M. R., Maitra, R. K., Silverman, R. H., and Torrence, P. F. (1998) Targeting RNase L to human immunodeficiency virus RNA with 2-5A-antisense. Antivir. Chem., Chemother. 9, 225-231.
10. Xiao, W., Li, G., Player, M. R., Maitra, R. K., Waller, C. F., Silverman, R. H., and Torrence, P. F. (1998) Nuclease-resistant composite 2′,5′-oligoadenylate-3′,5′-oligonucleotides for the targeted destruction of RNA: 2-5A-iso-antisense. J. Med. Chem. 41, 1531-1539.
11. Verheijen, J. C., van der Marel, G. A., van Boom, J. H., Bayly, S. F., Player, M. R., and Torrence, P. F. (1999) 2′,5′-Oligoadenylate-peptide nucleic acids (2-5A-PNAs) activate RNase L. Bioorg. Med. Chem. 7, 449-455.
12. Wang, Z., Chen, L., Bayly, S. F., and Torrence, P. F. (2000) Convergent synthesis of ribonuclease L-active 2′,5′-oligo-adenylate-peptide nucleic acids. Bioorg. Med. Chem. Lett. 10, 1357-1360.
13. Adah, S. A., Bayly, S. F., Cramer, H., Silverman, R. H., and Torrence, P. F. (2001) Chemistry and biochemistry of 2′, 5′-oligoadenylate-based antisense strategy. Curr. Med. Chem. 8, 1189-1212.
14. Xiao, W., Li, G., Lesiak, K., Dong, B., Silverman, R. H., and Torrence, P. F. (1994) Synthesis of a 5′-thiophosphate analogue of 2-5A, a phosphatase resistant activator of the 2-5A-dependent ribonuclease. Bioorg. Med. Chem. Lett. 4, 2609-2614.
15. Kitade, Y., Nakata, Y., Hirota, K., Maki, Y., Pabuccuoglu, A., and Torrence, P. F. (1991) 8-Methyladenosine-substituted analogues of 2-5A: synthesis and their biological activities. Nucleic Acids Res. 19, 4103-4108.
16. Hirota, K., Kitade, Y., Kanbe, Y., and Maki, Y. (1992) Convenient method for the synthesis of C-alkylated purine nucleosides: palladium-catalyzed cross-coupling reaction of halogenopurine nucleosides with trialkylaluminums. J. Org. Chem. 57, 5268-5270.
17. Inoue, H., Hayase, Y., Imura, A., Iwai. S., Miura, K., and Ohtsuka, E. (1987) Synthesis and hybridization studies on two complementary nona(2′-O-methyl)ribonucleotides. Nucleic Acids Res. 15, 6131-6148.
18. Carroll, S. S., Chen, E., Viscount, T., Geib, J., Sardana, M. K., Gehman, J., and Kuo, L. C. (1996) Cleavage of oligoribonucleotides by the 2′,5′-oligoadenylate-dependent ribonuclease L. J. Biol. Chem. 271, 4988-4992.
19. Yoshimura, A., Nakanishi, M., Yatome, C., and Kitade, Y. (2002) A comparative study on the biological properties of 2′,5′-oligoadenylates with purified human RNase L expressed in E. coli. J. Biochem. 132, 643-648.
20. Puglisi, J. D. and Tinoco, I., Jr. In Methods in Enzymology; Dahlberg, J. E., and Abelson, J. N., Eds.; Academic Press, Inc.: San Diego, 1989: Vol. 180, pp 304-325.